Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

BHEL receives LOI for Rs 10,00...
Gujarat Themis Q1 PAT falls ov...
Power Grid Q1 PAT rises 3% YoY...
IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...

Bafna Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 04:14 PM

85.00

0.62 (0.73%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-8.11%

Return (1Y)

Underperformed Nifty 50 by 33.67%
More Volatile

2.86%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.05%
Not so consistent

5/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

119

73

News & Announcements

Bafna Pharmaceuticals standalone net profit declines 72.81% in the March 2024 quarter

58 days ago

Bafna Pharmaceuticals to hold board meeting
60 days ago

Bafna Pharmaceuticals to hold board meeting

28 - May - 2024 12:00 AM | 60 days ago

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2024
Powered by Capital Market - Live News
Bafna Pharmaceuticals to declare Quarterly Result
175 days ago

Bafna Pharmaceuticals to declare Quarterly Result

03 - Feb - 2024 12:00 AM | 175 days ago

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.
Powered by Capital Market - Live News
Bafna Pharmaceuticals standalone net profit rises 54.04% in the September 2023 quarter
260 days ago

Bafna Pharmaceuticals standalone net profit rises 54.04% in the September 2023 quarter

10 - Nov - 2023 12:00 AM | 260 days ago

Net profit of Bafna Pharmaceuticals rose 54.04% to Rs 2.48 crore in the quarter ended September 2023 as against Rs 1.61 crore during the previous quarter ended September 2022. Sales rose 85.25% to Rs 40.68 crore in the quarter ended September 2023 as against Rs 21.96 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 40.68 21.96 85
OPM % 9.83 11.57 -
PBDT 3.72 2.73 36
PBT 2.48 1.61 54
NP 2.48 1.61 54
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60